<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31932096</PMID><DateCompleted><Year>2021</Year><Month>05</Month><Day>31</Day></DateCompleted><DateRevised><Year>2022</Year><Month>05</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0168-9525</ISSN><JournalIssue CitedMedium="Internet"><Volume>36</Volume><Issue>3</Issue><PubDate><Year>2020</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Trends in genetics : TIG</Title><ISOAbbreviation>Trends Genet</ISOAbbreviation></Journal><ArticleTitle>Omics in Neurodegenerative Disease: Hope or Hype?</ArticleTitle><Pagination><StartPage>152</StartPage><EndPage>159</EndPage><MedlinePgn>152-159</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.tig.2019.12.002</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0168-9525(19)30260-4</ELocationID><Abstract><AbstractText>The past 15 years have seen a boom in the use and integration of 'omic' approaches (limited here to genomic, transcriptomic, and epigenomic techniques) to study neurodegenerative disease in an unprecedented way. We first highlight advances in and the limitations of using such approaches in the neurodegenerative disease literature, with a focus on Alzheimer's disease (AD), Parkinson's disease (PD), frontotemporal lobar degeneration (FTLD), and amyotrophic lateral sclerosis (ALS). We next discuss how these studies can advance human health in the form of generating leads for downstream mechanistic investigation or yielding polygenic risk scores (PRSs) for prognostication. However, we argue that these approaches constitute a new form of molecular description, analogous to clinical or pathological description, that alone does not hold the key to solving these complex diseases.</AbstractText><CopyrightInformation>Copyright &#xa9; 2019 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Diaz-Ortiz</LastName><ForeName>Maria E</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Department of Bioengineering, School of Engineering and Applied Sciences, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen-Plotkin</LastName><ForeName>Alice S</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. Electronic address: chenplot@pennmedicine.upenn.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>T32 AG000255</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS115139</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U19 AG062418</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 NS082134</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 NS097056</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS082265</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG010124</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>01</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Trends Genet</MedlineTA><NlmUniqueID>8507085</NlmUniqueID><ISSNLinking>0168-9525</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000081122" MajorTopicYN="N">Epigenome</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057174" MajorTopicYN="N">Frontotemporal Lobar Degeneration</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016678" MajorTopicYN="N">Genome</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020412" MajorTopicYN="N">Multifactorial Inheritance</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="N">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059467" MajorTopicYN="N">Transcriptome</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">epigenomic</Keyword><Keyword MajorTopicYN="N">genomic</Keyword><Keyword MajorTopicYN="N">neurodegeneration</Keyword><Keyword MajorTopicYN="N">transcriptomic</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>9</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>11</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>12</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>1</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>1</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31932096</ArticleId><ArticleId IdType="mid">NIHMS1550138</ArticleId><ArticleId IdType="pmc">PMC7065657</ArticleId><ArticleId IdType="doi">10.1016/j.tig.2019.12.002</ArticleId><ArticleId IdType="pii">S0168-9525(19)30260-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>MacArthur J, et al. (2017) The new NHGRI-EBI Catalog of published genome-wide association studies (GWAS Catalog). Nucleic Acids Res 45, D896&#x2013;D901</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5210590</ArticleId><ArticleId IdType="pubmed">27899670</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallagher MD and Chen-Plotkin AS (2018) The Post-GWAS Era: From Association to Function. Am J Hum Genet 102, 717&#x2013;730</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5986732</ArticleId><ArticleId IdType="pubmed">29727686</ArticleId></ArticleIdList></Reference><Reference><Citation>Maraganore DM, et al. (2005) High-Resolution Whole-Genome Association Study of Parkinson Disease. The American Journal of Human Genetics 77, 685&#x2013;693</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1271381</ArticleId><ArticleId IdType="pubmed">16252231</ArticleId></ArticleIdList></Reference><Reference><Citation>Coon KD, et al. (2007) A high-density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer&#x2019;s disease. The Journal of clinical psychiatry 68, 613&#x2013;618</Citation><ArticleIdList><ArticleId IdType="pubmed">17474819</ArticleId></ArticleIdList></Reference><Reference><Citation>Schymick JC, et al. (2007) Genome-wide genotyping in amyotrophic lateral sclerosis and neurologically normal controls: first stage analysis and public release of data. The Lancet Neurology 6, 322&#x2013;328</Citation><ArticleIdList><ArticleId IdType="pubmed">17362836</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalls MA, et al. (2019) Expanding Parkinson&#x2019;s disease genetics: novel risk loci, genomic context, causal insights and heritable risk. bioRxiv, 388165</Citation><ArticleIdList><ArticleId IdType="pubmed">31701892</ArticleId></ArticleIdList></Reference><Reference><Citation>Diekstra FP, et al. (2014) C9orf72 and UNC13A are shared risk loci for amyotrophic lateral sclerosis and frontotemporal dementia: A genome-wide meta-analysis. Annals of Neurology 76, 120&#x2013;133</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4137231</ArticleId><ArticleId IdType="pubmed">24931836</ArticleId></ArticleIdList></Reference><Reference><Citation>Marioni RE, et al. (2018) GWAS on family history of Alzheimer&#x2019;s disease. Translational Psychiatry 8, 99.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5959890</ArticleId><ArticleId IdType="pubmed">29777097</ArticleId></ArticleIdList></Reference><Reference><Citation>Jansen IE, et al. (2019) Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer&#x2019;s disease risk. Nature Genetics 51, 404&#x2013;413</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6836675</ArticleId><ArticleId IdType="pubmed">30617256</ArticleId></ArticleIdList></Reference><Reference><Citation>Marigorta UM, et al. (2018) Replicability and Prediction: Lessons and Challenges from GWAS. Trends in Genetics 34, 504&#x2013;517</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6003860</ArticleId><ArticleId IdType="pubmed">29716745</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuyvers E and Sleegers K (2016) Genetic variations underlying Alzheimer&#x2019;s disease: evidence from genome-wide association studies and beyond. The Lancet Neurology 15, 857&#x2013;868</Citation><ArticleIdList><ArticleId IdType="pubmed">27302364</ArticleId></ArticleIdList></Reference><Reference><Citation>van Rheenen W, et al. (2016) Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis. Nature Genetics 48, 1043.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5556360</ArticleId><ArticleId IdType="pubmed">27455348</ArticleId></ArticleIdList></Reference><Reference><Citation>Lambert J-C, et al. (2013) Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer&#x2019;s disease. Nature Genetics 45, 1452.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3896259</ArticleId><ArticleId IdType="pubmed">24162737</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrari R, et al. (2014) Frontotemporal dementia and its subtypes: a genome-wide association study. The Lancet Neurology 13, 686&#x2013;699</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4112126</ArticleId><ArticleId IdType="pubmed">24943344</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalls MA, et al. (2014) Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson&#x2019;s disease. Nature Genetics 46, 989.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4146673</ArticleId><ArticleId IdType="pubmed">25064009</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang M, et al. (2018) A C6orf10/LOC101929163 locus is associated with age of onset in C9orf72 carriers. Brain 141, 2895&#x2013;2907</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6158742</ArticleId><ArticleId IdType="pubmed">30252044</ArticleId></ArticleIdList></Reference><Reference><Citation>Jansen IE, et al. (2019) Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer&#x2019;s disease risk. Nat Genet 51, 404&#x2013;413</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6836675</ArticleId><ArticleId IdType="pubmed">30617256</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalls MA, et al. (2019) Expanding Parkinson&#x2019;s disease genetics: novel risk loci, genomic context, causal insights and heritable risk. bioRxiv, 388165</Citation><ArticleIdList><ArticleId IdType="pubmed">31701892</ArticleId></ArticleIdList></Reference><Reference><Citation>Creyghton MP, et al. (2010) Histone H3K27ac separates active from poised enhancers and predicts developmental state. Proceedings of the National Academy of Sciences 107, 21931&#x2013;21936</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3003124</ArticleId><ArticleId IdType="pubmed">21106759</ArticleId></ArticleIdList></Reference><Reference><Citation>Deaton AM and Bird A (2011) CpG islands and the regulation of transcription. Genes &amp; Development 25, 1010&#x2013;1022</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3093116</ArticleId><ArticleId IdType="pubmed">21576262</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang D, et al. (2017) A meta-analysis of genome-wide association studies identifies 17 new Parkinson&#x2019;s disease risk loci. Nature Genetics 49, 1511.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5812477</ArticleId><ArticleId IdType="pubmed">28892059</ArticleId></ArticleIdList></Reference><Reference><Citation>Hannon E, et al. (2019) Genetic risk variants for brain disorders are enriched in cortical H3K27ac domains. Molecular Brain 12, 7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6348673</ArticleId><ArticleId IdType="pubmed">30691483</ArticleId></ArticleIdList></Reference><Reference><Citation>Marzi SJ, et al. (2018) A histone acetylome-wide association study of Alzheimer&#x2019;s disease identifies disease-associated H3K27ac differences in the entorhinal cortex. Nature Neuroscience 21, 1618&#x2013;1627</Citation><ArticleIdList><ArticleId IdType="pubmed">30349106</ArticleId></ArticleIdList></Reference><Reference><Citation>Consortium G, et al. (2017) Genetic effects on gene expression across human tissues. Nature 550, 204.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5776756</ArticleId><ArticleId IdType="pubmed">29022597</ArticleId></ArticleIdList></Reference><Reference><Citation>Kunkle BW, et al. (2019) Genetic meta-analysis of diagnosed Alzheimer&#x2019;s disease identifies new risk loci and implicates Abeta, tau, immunity and lipid processing. Nat Genet 51, 414&#x2013;430</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6463297</ArticleId><ArticleId IdType="pubmed">30820047</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper-Knock J, et al. (2012) Gene expression profiling in human neurodegenerative disease. Nature Reviews Neurology 8, 518.</Citation><ArticleIdList><ArticleId IdType="pubmed">22890216</ArticleId></ArticleIdList></Reference><Reference><Citation>Brohawn DG, et al. (2016) RNAseq Analyses Identify Tumor Necrosis Factor-Mediated Inflammation as a Major Abnormality in ALS Spinal Cord. PLoS One 11, e0160520.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4972368</ArticleId><ArticleId IdType="pubmed">27487029</ArticleId></ArticleIdList></Reference><Reference><Citation>Ladd AC, et al. (2017) RNA-seq analyses reveal that cervical spinal cords and anterior motor neurons from amyotrophic lateral sclerosis subjects show reduced expression of mitochondrial DNA-encoded respiratory genes, and rhTFAM may correct this respiratory deficiency. Brain research 1667, 74&#x2013;83</Citation><ArticleIdList><ArticleId IdType="pubmed">28511992</ArticleId></ArticleIdList></Reference><Reference><Citation>Annese A, et al. (2018) Whole transcriptome profiling of Late-Onset Alzheimer&#x2019;s Disease patients provides insights into the molecular changes involved in the disease. Scientific Reports 8, 4282.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5844946</ArticleId><ArticleId IdType="pubmed">29523845</ArticleId></ArticleIdList></Reference><Reference><Citation>Borrageiro G, et al. (2018) A review of genome-wide transcriptomics studies in Parkinson&#x2019;s disease. European Journal of Neuroscience 47, 1&#x2013;16</Citation><ArticleIdList><ArticleId IdType="pubmed">29068110</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett JP Jr., et al. (2019) RNA Sequencing Reveals Small and Variable Contributions of Infectious Agents to Transcriptomes of Postmortem Nervous Tissues From Amyotrophic Lateral Sclerosis, Alzheimer&#x2019;s Disease and Parkinson&#x2019;s Disease Subjects, and Increased Expression of Genes From Disease-Activated Microglia. Frontiers in neuroscience 13, 235.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6447612</ArticleId><ArticleId IdType="pubmed">30983949</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel H, et al. (2019) A Meta-Analysis of Alzheimer&#x2019;s Disease Brain Transcriptomic Data. Journal of Alzheimer&#x2019;s disease : JAD 68, 1635&#x2013;1656</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6484273</ArticleId><ArticleId IdType="pubmed">30909231</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Deerlin VM, et al. (2010) Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions. Nature Genetics 42, 234.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2828525</ArticleId><ArticleId IdType="pubmed">20154673</ArticleId></ArticleIdList></Reference><Reference><Citation>Tropea TF, et al. (2019) TMEM106B Effect on cognition in Parkinson disease and frontotemporal dementia. Annals of Neurology 85, 801&#x2013;811</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6953172</ArticleId><ArticleId IdType="pubmed">30973966</ArticleId></ArticleIdList></Reference><Reference><Citation>Vass R, et al. (2011) Risk genotypes at TMEM106B are associated with cognitive impairment in amyotrophic lateral sclerosis. Acta Neuropathologica 121, 373&#x2013;380</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3095217</ArticleId><ArticleId IdType="pubmed">21104415</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallagher MD, et al. (2014) TMEM106B is a genetic modifier of frontotemporal lobar degeneration with C9orf72 hexanucleotide repeat expansions. Acta Neuropathologica 127, 407&#x2013;418</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4003885</ArticleId><ArticleId IdType="pubmed">24442578</ArticleId></ArticleIdList></Reference><Reference><Citation>Cruchaga C, et al. (2011) Association of TMEM106B gene polymorphism with age at onset in granulin mutation carriers and plasma granulin protein levels. Archives of neurology 68, 581&#x2013;586</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3090529</ArticleId><ArticleId IdType="pubmed">21220649</ArticleId></ArticleIdList></Reference><Reference><Citation>Finch N, et al. (2011) TMEM106B regulates progranulin levels and the penetrance of FTLD in GRN mutation carriers. Neurology 76, 467&#x2013;474</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3034409</ArticleId><ArticleId IdType="pubmed">21178100</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallagher MD, et al. (2017) A Dementia-Associated Risk Variant near TMEM106B Alters Chromatin Architecture and Gene Expression. The American Journal of Human Genetics 101, 643&#x2013;663</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5673619</ArticleId><ArticleId IdType="pubmed">29056226</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen-Plotkin AS, et al. (2012) TMEM106B, the Risk Gene for Frontotemporal Dementia, Is Regulated by the microRNA-132/212 Cluster and Affects Progranulin Pathways. The Journal of Neuroscience 32, 11213&#x2013;11227</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3446826</ArticleId><ArticleId IdType="pubmed">22895706</ArticleId></ArticleIdList></Reference><Reference><Citation>Busch JI, et al. (2016) Increased expression of the frontotemporal dementia risk factor TMEM106B causes C9orf72-dependent alterations in lysosomes. Human Molecular Genetics 25, 2681&#x2013;2697</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5181637</ArticleId><ArticleId IdType="pubmed">27126638</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein ZA, et al. (2017) Loss of TMEM106B Ameliorates Lysosomal and Frontotemporal Dementia-Related Phenotypes in Progranulin-Deficient Mice. Neuron 95, 281&#x2013;296.e286</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5558861</ArticleId><ArticleId IdType="pubmed">28728022</ArticleId></ArticleIdList></Reference><Reference><Citation>Parkinson J (1817) An Essay on the Shaking Palsy.</Citation><ArticleIdList><ArticleId IdType="pubmed">11983801</ArticleId></ArticleIdList></Reference><Reference><Citation>Alzheimer A (1907) &#xdc;ber eine eigenartige Erkrankung der Hirnrinde [article in German]. Allg Z Psych Psych-gerich Med 64, 146&#x2013;148</Citation></Reference><Reference><Citation>Forster E and Lewy F (1912) Paralysis agitans. Pathologische Anatomie. Handbuch der Neurologie 20, 920&#x2013;933</Citation></Reference><Reference><Citation>Polymeropoulos MH, et al. (1997) Mutation in the &#x3b1;-Synuclein Gene Identified in Families with Parkinson&#x2019;s Disease. Science 276, 2045&#x2013;2047</Citation><ArticleIdList><ArticleId IdType="pubmed">9197268</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis CA, et al. (2018) The Encyclopedia of DNA elements (ENCODE): data portal update. Nucleic Acids Res 46, D794&#x2013;D801</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5753278</ArticleId><ArticleId IdType="pubmed">29126249</ArticleId></ArticleIdList></Reference><Reference><Citation>Doudna JA and Charpentier E (2014) The new frontier of genome engineering with CRISPR-Cas9. Science 346, 1258096</Citation><ArticleIdList><ArticleId IdType="pubmed">25430774</ArticleId></ArticleIdList></Reference><Reference><Citation>Claussnitzer M, et al. (2015) FTO Obesity Variant Circuitry and Adipocyte Browning in Humans. New England Journal of Medicine 373, 895&#x2013;907</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4959911</ArticleId><ArticleId IdType="pubmed">26287746</ArticleId></ArticleIdList></Reference><Reference><Citation>Harold D, et al. (2009) Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer&#x2019;s disease. Nat Genet 41, 1088&#x2013;1093</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2845877</ArticleId><ArticleId IdType="pubmed">19734902</ArticleId></ArticleIdList></Reference><Reference><Citation>Hollingworth P, et al. (2011) Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer&#x2019;s disease. Nature Genetics 43, 429.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3084173</ArticleId><ArticleId IdType="pubmed">21460840</ArticleId></ArticleIdList></Reference><Reference><Citation>Lambert JC, et al. (2009) Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer&#x2019;s disease. Nat Genet 41, 1094&#x2013;1099</Citation><ArticleIdList><ArticleId IdType="pubmed">19734903</ArticleId></ArticleIdList></Reference><Reference><Citation>Marioni RE, et al. (2019) Correction: GWAS on family history of Alzheimer&#x2019;s disease. Translational Psychiatry 9, 161.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6554304</ArticleId><ArticleId IdType="pubmed">31171767</ArticleId></ArticleIdList></Reference><Reference><Citation>Naj AC, et al. (2011) Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer&#x2019;s disease. Nature Genetics 43, 436.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3090745</ArticleId><ArticleId IdType="pubmed">21460841</ArticleId></ArticleIdList></Reference><Reference><Citation>Seshadri S, et al. (2010) Genome-wide Analysis of Genetic Loci Associated With Alzheimer Disease. Jama 303, 1832&#x2013;1840</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2989531</ArticleId><ArticleId IdType="pubmed">20460622</ArticleId></ArticleIdList></Reference><Reference><Citation>Consortium I.P.s.D.G. (2011) Imputation of sequence variants for identification of genetic risks for Parkinson&#x2019;s disease: a meta-analysis of genome-wide association studies. The Lancet 377, 641&#x2013;649</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3696507</ArticleId><ArticleId IdType="pubmed">21292315</ArticleId></ArticleIdList></Reference><Reference><Citation>Fung H-C, et al. (2006) Genome-wide genotyping in Parkinson&#x2019;s disease and neurologically normal controls: first stage analysis and public release of data. The Lancet Neurology 5, 911&#x2013;916</Citation><ArticleIdList><ArticleId IdType="pubmed">17052657</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamza TH, et al. (2010) Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson&#x2019;s disease. Nat Genet 42, 781&#x2013;785</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2930111</ArticleId><ArticleId IdType="pubmed">20711177</ArticleId></ArticleIdList></Reference><Reference><Citation>Pankratz N, et al. (2012) Meta-analysis of Parkinson&#x2019;s Disease: Identification of a novel locus, RIT2. Annals of Neurology 71, 370&#x2013;384</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3354734</ArticleId><ArticleId IdType="pubmed">22451204</ArticleId></ArticleIdList></Reference><Reference><Citation>Satake W, et al. (2009) Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson&#x2019;s disease. Nature Genetics 41, 1303.</Citation><ArticleIdList><ArticleId IdType="pubmed">19915576</ArticleId></ArticleIdList></Reference><Reference><Citation>Sim&#xf3;n-S&#xe1;nchez J, et al. (2009) Genome-wide association study reveals genetic risk underlying Parkinson&#x2019;s disease. Nature Genetics 41, 1308.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2787725</ArticleId><ArticleId IdType="pubmed">19915575</ArticleId></ArticleIdList></Reference><Reference><Citation>Team RC (2016) R: A language and environment for statistical computing. R Foundation for Statistical Computing</Citation></Reference><Reference><Citation>Gratten J, et al. (2017) Whole-exome sequencing in amyotrophic lateral sclerosis suggests NEK1 is a risk gene in Chinese. Genome medicine 9, 97.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5693798</ArticleId><ArticleId IdType="pubmed">29149916</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>